Novel Analgesics at a Snail’s Pace

Studying cone snail venom has yielded novel pain pathways, but the peptides that function as toxins are difficult to translate into drugs.

Written byBob Grant
| 3 min read
geography cone shell, Conus geographus, hunting at night, Lady Elliot Island, Great Barrier Reef Marine Park, South Pacific Ocean, Queensland, Australia
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In the 1970s, University of Utah researcher Baldomero Olivera heard stories of Filipino fishermen dying after pulling in their nets. Their catches turned out to contain Conus geographus, a marine mollusk that produces some of the most potent venom of any cone snail species. The ultimate cause of death, then, seemed clear. But the details of how the cone snail toxin had killed the fishermen were more curious. According to medical reports, the men were not writhing in agony as their lives slipped from their grasp, leading researchers and clinicians to dub the tragic outcome a “painless death.”

“They didn’t cry out in pain, they weren’t doubling over, they weren’t getting swollen like you kind of do from a wasp sting or from a snakebite, where you get this massive inflammation,” says Mandë Holford, a biochemist at Hunter College and CUNY Graduate Center and the American Museum of Natural History ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

January 2018

The Science of Pain

New research on an age-old ailment

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies